Virginia Retirement Systems Et Al Myovant Sciences Ltd. Transaction History

Virginia Retirement Systems Et Al

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 21, 2022	SELL	$11.38 - $16.4 $285,638 - $411,639	-25,100 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$14.31 - $23.87 $54,378 - $90,706	3,800 Added 17.84%	25,100 $391,000
Q3 2021 Oct 21, 2021	BUY	$18.94 - $26.99 $403,422 - $574,887	21,300 New	21,300 $478,000
Q1 2020 May 12, 2020	SELL	$6.55 - $14.76 $84,495 - $190,404	-12,900 Closed	0 $0
Q4 2019 Jan 27, 2020	SELL	$4.2 - $19.21 $27,300 - $124,865	-6,500 Reduced 33.51%	12,900 $200,000
Q3 2019 Oct 22, 2019	BUY	$5.19 - $9.46 $100,686 - $183,524	19,400 New	19,400 $101,000

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.